HIPAA NOTICE OF PRIVACY PRACTICES

Effective Date: This Notice is effective February 16, 2026.

THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.

This Notice of Privacy Practices (“Notice”) describes the legal obligations of all group health plans (with the exception of the South Boston On-Site Medical Plan, which maintains its own Notice) in the United States sponsored, administered, and self-insured by The Procter & Gamble Company and its affiliates (collectively the “Plan”), and your legal rights regarding your protected health information held by the Plan under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and, to the extent applicable, the Part 2 records the Plan may maintain pursuant to the Confidentiality of Substance Use Disorder Patient Records, 42 CFR Part 2 (“Part 2”). Among other things, this Notice describes how your protected health information and Part 2 records (both as defined below, respectively) may be used and disclosed to carry out treatment, payment, or health care operations, or for any other purposes that are permitted or required by law. HIPAA requires the Plan to provide this Notice to you.

The HIPAA Privacy Rule protects certain medical information known as “protected health information.” Under HIPAA, protected health information is individually identifiable health information, including demographic information, collected from you or created or received by a health care provider, a health care clearinghouse, a health plan, or your employer in its role as a sponsor of a group health plan, that relates to (1) your past, present, or future physical or mental health or condition; (2) the provision of health care to you; or (3) the past, present, or future payment for the provision of health care to you. For purposes of this Notice, we will refer to your protected health information as either “medical information about you” or “your medical information.” Part 2 protects certain information the Plan may receive or maintain from a Part 2 program (i.e., certain federally assisted programs related to substance use disorder diagnosis, treatment, or referrals). This includes diagnosis, treatment and treatment referral information, billing information, emails, voice mails, texts, and other patient-identifying information. For purposes of this Notice, we will refer to your records related to Part 2 programs as “Part 2 records.”

If you have any questions about this Notice or about the Plan’s privacy practices, please contact the Plan’s Privacy Official at corporateprivacy.im@pg.com or the Director, U.S. Health and Wellness Benefits, GBS People Services (or equivalent).